Crescent Biopharma, Inc. (CBIO)
11.85
-0.37
(-3.03%)
USD |
NASDAQ |
Dec 19, 16:00
11.88
+0.03
(+0.25%)
After-Hours: 20:00
Crescent Biopharma EPS Diluted (Quarterly): -1.488 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.6991 |
| Viridian Therapeutics, Inc. | -0.423 |
| DiaMedica Therapeutics, Inc. | -0.1737 |
| Denali Therapeutics, Inc. | -0.736 |
| Praxis Precision Medicines, Inc. | -3.364 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -24.61M |
| Total Expenses (Quarterly) | 24.61M |
| Enterprise Value | 37.10M |
| Earnings Yield | -185.4% |
| Normalized Earnings Yield | -166.92 |